The sale of antidepressants and mood elevators in India increased significantly, growing by 64% to Rs 2,536 crore since 2020, ...

The sale of antidepressants and mood elevators in India surged from Rs 1,540 crore in 2020 to Rs 2,536 crore by Nov 2024.

They suggest other fast-acting antidepressants could offer a competitive challenge to J&J's drug, including Axsome Therapeutics' recently approved Auvelity (bupropion/dextromethorphan), Sage ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

President Joe Biden on Friday blocked US Steel’s $14 billion sale to Japanese giant Nippon Steel on national security concerns, creating new uncertainty ... drive the bull market rally.

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

The data revealed that a combination of Escitalopram and Clonazepam was on top of the list, seeing an increase of 59.35% in sales since 2020.

After Neumora Therapeutics (NMRA) announced the Phase 3 KOASTAL-1 Study of navacaprant for the treatment of major depressive disorder did not ...

Stifel Nicolaus analyst Paul Matteis has maintained their bullish stance on NMRA stock, giving a Buy rating today.Don't Miss Our New Year's ...